기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
실험견에서 Metoprolol 약리효과의 약동/력학적 검토
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • 실험견에서 Metoprolol 약리효과의 약동/력학적 검토
  • Pharmacokinetic/Pharmacodynamic Analysis of Metoprolol in Dogs
저자명
오동진(Dong-Jin Oh),장인진(In-Jin Jang),이경훈(Kyung-Hun Lee),임동석(Dong-Seok Yim),김형기(Hyung-Kee Kim),신상구(Sang-Goo Shin),박찬웅(Chan-Woong Par
간행물명
대한약리학잡지
권/호정보
1995년|31권 2호(통권55호)|pp.251-260 (10 pages)
발행정보
대한약리학회|한국
파일정보
정기간행물|KOR|
PDF텍스트(0.26MB)
주제분야
의약학
서지반출

영문초록

Pharmacokinetics and pharmacodynamics of metoprolol, a selective beta-l blocker, were examined for 360 minutes after intravenous bolus administration of metoprolol to 6 dogs. Plasma concentration and excreted amount in the urine metoprolol were measured by liquid chromatography with fluorescence detection. PR interval and heart rate were measured by ECG monitoring. Blood pressure was monitored through intraarterial catheter in femoral artery and cardiac output by thermodilution method using Swan-Ganz catheter. To analyze the effect site concentration-response relationship, plasma concentration and pharmacological effects were simultaneously fitted to a two pharmacokinetic compartment linked to pharmacodynamic model with NONLIN program. Results are as follows. 1) The plasma concentration of metoprolol after intrvenous injection decreased biexponentially. The terminal half-life estimated was 1.33 ± 0.40 hours and the volume of distribution at steady state (Vdss) and the total body clearance were 1.04 ± 0.4 L/kg, 6.55 ± 2.21 L/hr, respectively. The central compartment volume of distribution and peripheral compartment volume of distribution were 0.35 ± 0.14L/kg and 0.69 ± 0.34L/kg. The renal clearance and intercompartment clearance were 0.53 ± 0.25 L/min and 0.35 ± 0.19 L/min. 2) Simulated biophase concentration-response curve shows hyperbolic relationship and the estimated concentration-effect relationship was best explained by Emax model when the prolongation of PR interval and the reduction of the heart rate were used as pharmacodynamic parameters. Emax and EC50 were estimated to be 26.3 ± 4.7 msec and 88.8 ± 82.3 g/ml for PR interval, and 48.7 ± 18.8 beats/min and 113.5 ± 78.7 ng/ml for heart rate, respectively. 3) The changes of cardiac output-effect site concentration relationship was best fitted by a linear model and the slope of the relationship was 0.005 ± 0.003. Diastolic blood pressure-effect site concentration relationship was also explained by the linear model and the slope of the relationship was 0.038 ± 0.034.

구매하기 (3,000)